Ogawa, Hisao

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine

Atherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular Health

Cited by 9,482

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet

Inflammatory mediators and NSAID effectsAntiplatelet Therapy and Cardiovascular Diseases

Cited by 1,497

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Ridker, P. M., MacFadyen, J. G., Thuren, T., Everett, B. M., Libby, P., Glynn, R. J., Ridker, P., Lorenzatti, A., Krum, H., Varigos, J., et al. (2017) · The Lancet

Inflammasome and immune disordersInflammatory Biomarkers in Disease Prognosis

Cited by 1,344

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes<subtitle>A Randomized Controlled Trial</subtitle>

Ogawa, H. (2008) · JAMA

Antiplatelet Therapy and Cardiovascular DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 776

Hyperglycemia rapidly suppresses flow-mediated endothelium- dependent vasodilation of brachial artery

Kawano, H., Motoyama, T., Hirashima, O., Hirai, N., Miyao, Y., Sakamoto, T., Kugiyama, K., Ogawa, H., & Yasue, H. (1999) · Journal of the American College of Cardiology

Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease Prevention

Cited by 676

JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome

Kimura, K., Kimura, T., Ishihara, M., Nakagawa, Y., Nakao, K., Miyauchi, K., Sakamoto, T., Tsujita, K., Hagiwara, N., Miyazaki, S., et al. (2019) · Circulation Journal

Acute Myocardial Infarction ResearchCoronary Interventions and Diagnostics

Cited by 565

Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention

Tsujita, K., Sugiyama, S., Sumida, H., Shimomura, H., Yamashita, T., Yamanaga, K., Komura, N., Sakamoto, K., Oka, H., Nakao, K., et al. (2015) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthCoronary Interventions and Diagnostics

Cited by 459

Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease

Kugiyama, K., Doi, H., Takazoe, K., Kawano, H., Soejima, H., Mizuno, Y., Tsunoda, R., Sakamoto, T., Nakano, T., Nakajima, K., et al. (1999) · Circulation

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 284

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation

Fruchart, J.-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Després, J.-P., et al. (2019) · Cardiovascular Diabetology

Peroxisome Proliferator-Activated ReceptorsLipoproteins and Cardiovascular Health

Cited by 140

Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: effect of vitamin C

Motoyama, T., Kawano, H., Kugiyama, K., Hirashima, O., Ohgushi, M., Yoshimura, M., Ogawa, H., & Yasue, H. (1997) · American Journal of Physiology-Heart and Circulatory Physiology

Cardiovascular Health and Disease PreventionNitric Oxide and Endothelin Effects

Cited by 128

Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men

Nishiyama, K., Yasue, H., Moriyama, Y., Tsunoda, R., Ogawa, H., Yoshimura, M., & Kugiyama, K. (2001) · American Heart Journal

Heart Rate Variability and Autonomic ControlCircadian rhythm and melatonin

Cited by 113

Exercise therapy correlates with improving renal function through modifying lipid metabolism in patients with cardiovascular disease and chronic kidney disease

Toyama, K., Sugiyama, S., Oka, H., Sumida, H., & Ogawa, H. (2010) · Journal of Cardiology

Cardiovascular and exercise physiologyChronic Kidney Disease and Diabetes

Cited by 113

Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion

Dong, Y.-F., Kataoka, K., Toyama, K., Sueta, D., Koibuchi, N., Yamamoto, E., Yata, K., Tomimoto, H., Ogawa, H., & Kim-Mitsuyama, S. (2011) · Hypertension

Neurological Disease Mechanisms and TreatmentsRenin-Angiotensin System Studies

Cited by 109

Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus

Fukushima, H., Sugiyama, S., Honda, O., Koide, S., Nakamura, S., Sakamoto, T., Yoshimura, M., Ogawa, H., Fujioka, D., & Kugiyama, K. (2004) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 91

Endothelial function fluctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina

Kawano, H., Motoyama, T., Yasue, H., Hirai, N., Waly, H. M., Kugiyama, K., & Ogawa, H. (2002) · Journal of the American College of Cardiology

Cardiovascular Health and Disease PreventionNitric Oxide and Endothelin Effects

Cited by 73

Subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes in patients with acute decompensated heart failure

Hayashi, T., Hasegawa, T., Kanzaki, H., Funada, A., Amaki, M., Takahama, H., Ohara, T., Sugano, Y., Yasuda, S., Ogawa, H., et al. (2016) · ESC Heart Failure

Thyroid Disorders and TreatmentsHeart Failure Treatment and Management

Cited by 71

Apixaban for the treatment of Japanese subjects with acute venous thromboembolism (AMPLIFY-J Study)

Nakamura, M., Nishikawa, M., Komuro, I., Kitajima, I., Uetsuka, Y., Yamagami, T., Minamiguchi, H., Yoshimatsu, R., Tanabe, K., Matsuoka, N., et al. (2015) · Circulation Journal

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

Cited by 67

Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study

Matsuzawa, Y., Ogawa, H., Kimura, K., Konishi, M., Kirigaya, J., Fukui, K., Tsukahara, K., Shimizu, H., Iwabuchi, K., Yamada, Y., et al. (2020) · Hypertension Research

COVID-19 Clinical Research StudiesRenin-Angiotensin System Studies

Cited by 52

Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction

Sakamoto, T., Yasue, H., Ogawa, H., Misumi, I., & Masuda, T. (1992) · The American Journal of Cardiology

Acute Myocardial Infarction ResearchBlood Coagulation and Thrombosis Mechanisms

Cited by 49

Demonstration of anatomic reentrant circuit in verapamil-sensitive atrial tachycardia originating from the atrioventricular annulus other than the vicinity of the atrioventricular node

Yamabe, H., Okumura, K., Koyama, J., Kanazawa, H., Hoshiyama, T., & Ogawa, H. (2014) · The American Journal of Cardiology

Cardiac Arrhythmias and TreatmentsCardiac electrophysiology and arrhythmias

Cited by 26